Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives.
Takaoka A, Cao K, Oste EM, Nagasaki T, Paik DC.
Biosci Rep. 2019 May 3;39(5). pii: BSR20182392. doi: 10.1042/BSR20182392. Print 2019 May 31.
Contact Dermatitis to Medications and Skin Products.
Nguyen HL, Yiannias JA.
Clin Rev Allergy Immunol. 2019 Feb;56(1):41-59. doi: 10.1007/s12016-018-8705-0. Review.
Preservatives as important etiologic factors of allergic contact dermatitis.
Kręcisz B, Chomiczewska-Skóra D, Kieć-Świerczyńska M.
Med Pr. 2015;66(3):327-32. doi: 10.13075/mp.5893.00176.
Cosmetic preservatives as therapeutic corneal and scleral tissue cross-linking agents.
Babar N, Kim M, Cao K, Shimizu Y, Kim SY, Takaoka A, Trokel SL, Paik DC.
Invest Ophthalmol Vis Sci. 2015 Jan 29;56(2):1274-82. doi: 10.1167/iovs.14-16035.
Sensitivity of petrolatum and aqueous vehicles for detecting allergy to imidazolidinylurea, diazolidinylurea, and DMDM hydantoin: a retrospective analysis from the North American Contact Dermatitis Group.
Rietschel RL, Warshaw EM, Sasseville D, Fowler JF Jr, DeLeo VA, Belsito DV, Taylor JS, Storrs FJ, Mathias CG, Maibach HI, Marks JG Jr, Zug KA, Pratt M; North American Contact Dermatitis Group.
Dermatitis. 2007 Sep;18(3):155-62.
Contact allergy from DMDM hydantoin, 1994-2000.
Uter W, Frosch PJ; IVDK Study Group and the German Contact Dermatitis Research Group, DKG.
Contact Dermatitis. 2002 Jul;47(1):57-8.